Company news
Shield Therapeutics PLC news in 2019
Shield Therapeutics PLC's news releases, calls and decks from 2019, newest first.
QCA Corporate Governance Code
November 25, 2019
Shield Therapeutics (STX): More choice for clin...
October 30, 2019
Positive results presented at UEG Week 2019
October 22, 2019
Shield Therapeutics (STX): FDA approval ushers...
September 2, 2019
Shield Therapeutics (STX) FDA approval opens do...
August 5, 2019
FDA approves Feraccru® with a broad label
July 26, 2019
Additional Listing
July 2, 2019
Update on Legal Proceedings
June 3, 2019
Shield Therapeutics (STX): All in the execution
May 13, 2019
Appointment of Joint Broker
May 8, 2019
2018 Annual Report and 2019 AGM Notice
April 30, 2019
PDMR Acquisition of Shares
April 26, 2019
Major extension to approval in Switzerland
April 24, 2019
PDMR Acquisition of Shares and Additional Listing
April 17, 2019
Final Results
April 3, 2019
Change of Adviser
April 1, 2019
Positive decision on Feraccru®'s process patent
March 14, 2019
Positive results for Feraccru® in AEGIS-H2H study
March 4, 2019
Positive results of AEGIS-CKD study
January 29, 2019
Shield Therapeutics (STX): Cast-iron investment
January 28, 2019